These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 36165006)

  • 1. MDMA-assisted psychotherapy for post-traumatic stress disorder: The devil is in the detail.
    Bedi G; Cotton SM; Guerin AA; Jackson HJ
    Aust N Z J Psychiatry; 2023 Apr; 57(4):476-481. PubMed ID: 36165006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Emerging Field of Psychedelic Psychotherapy.
    Barber GS; Aaronson ST
    Curr Psychiatry Rep; 2022 Oct; 24(10):583-590. PubMed ID: 36129571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress and promise for the MDMA drug development program.
    Feduccia AA; Holland J; Mithoefer MC
    Psychopharmacology (Berl); 2018 Feb; 235(2):561-571. PubMed ID: 29152674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MDMA to Treat PTSD in Adults.
    Latimer D; Stocker MD; Sayers K; Green J; Kaye AM; Abd-Elsayed A; Cornett EM; Kaye AD; Varrassi G; Viswanath O; Urits I
    Psychopharmacol Bull; 2021 Jun; 51(3):125-149. PubMed ID: 34421149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial.
    Mithoefer MC; Mithoefer AT; Feduccia AA; Jerome L; Wagner M; Wymer J; Holland J; Hamilton S; Yazar-Klosinski B; Emerson A; Doblin R
    Lancet Psychiatry; 2018 Jun; 5(6):486-497. PubMed ID: 29728331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychedelic Therapy: A Primer for Primary Care Clinicians-3,4-Methylenedioxy-methamphetamine (MDMA).
    Shinozuka K; Tabaac BJ; Arenas A; Beutler BD; Cherian K; Evans VD; Fasano C; Muir OS
    Am J Ther; 2024 Mar-Apr 01; 31(2):e141-e154. PubMed ID: 38518271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of potential psychedelic treatments for PTSD.
    Henner RL; Keshavan MS; Hill KP
    J Neurol Sci; 2022 Aug; 439():120302. PubMed ID: 35700643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating posttraumatic stress disorder and alcohol use disorder comorbidity: Current pharmacological therapies and the future of MDMA-integrated psychotherapy.
    Gully BJ; Eaton E; Capone C; Haass-Koffler CL
    J Psychopharmacol; 2023 Dec; 37(12):1182-1189. PubMed ID: 38009477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cost-effectiveness of MDMA-assisted psychotherapy for the treatment of chronic, treatment-resistant PTSD.
    Marseille E; Kahn JG; Yazar-Klosinski B; Doblin R
    PLoS One; 2020; 15(10):e0239997. PubMed ID: 33052965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there a case for MDMA-assisted psychotherapy in the UK?
    Sessa B
    J Psychopharmacol; 2007 Mar; 21(2):220-4. PubMed ID: 17329304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Selective Serotonin Reuptake Inhibitor Use on 3,4-Methylenedioxymethamphetamine-Assisted Therapy for Posttraumatic Stress Disorder: A Review of the Evidence, Neurobiological Plausibility, and Clinical Significance.
    Price CM; Feduccia AA; DeBonis K
    J Clin Psychopharmacol; 2022 Sep-Oct 01; 42(5):464-469. PubMed ID: 36018231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychedelics and Psychedelic-Assisted Psychotherapy.
    Reiff CM; Richman EE; Nemeroff CB; Carpenter LL; Widge AS; Rodriguez CI; Kalin NH; McDonald WM;
    Am J Psychiatry; 2020 May; 177(5):391-410. PubMed ID: 32098487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic effect of increased openness: Investigating mechanism of action in MDMA-assisted psychotherapy.
    Wagner MT; Mithoefer MC; Mithoefer AT; MacAulay RK; Jerome L; Yazar-Klosinski B; Doblin R
    J Psychopharmacol; 2017 Aug; 31(8):967-974. PubMed ID: 28635375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy and safety of MDMA-assisted psychotherapy for treatment of posttraumatic stress disorder: A systematic review and meta-analysis from randomized controlled trials.
    Yang J; Wang N; Luo W; Gao J
    Psychiatry Res; 2024 Sep; 339():116043. PubMed ID: 38896930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Psychedelic Assisted Therapy" Must Not Be Retired.
    Deckel GM; Lepow LA; Guss J
    Am J Psychiatry; 2024 Jan; 181(1):77-78. PubMed ID: 38161309
    [No Abstract]   [Full Text] [Related]  

  • 16. Why MDMA therapy for alcohol use disorder? And why now?
    Sessa B
    Neuropharmacology; 2018 Nov; 142():83-88. PubMed ID: 29126911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic investigation with MDMA (ecstasy)].
    Bouso Saiz JC; Gómez-Jarabo G
    Med Clin (Barc); 2003 Sep; 121(8):318; author reply 318-9. PubMed ID: 14499096
    [No Abstract]   [Full Text] [Related]  

  • 18. Turn on and tune in to evidence-based psychedelic research.
    Sessa B
    Lancet Psychiatry; 2015 Jan; 2(1):10-2. PubMed ID: 26359597
    [No Abstract]   [Full Text] [Related]  

  • 19. The Psychopharmacology of ±3,4 Methylenedioxymethamphetamine and its Role in the Treatment of Posttraumatic Stress Disorder.
    Amoroso T
    J Psychoactive Drugs; 2015; 47(5):337-44. PubMed ID: 26579955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is needed for the roll-out of psychedelic treatments?
    Xenakis SN; Shannon SM
    Curr Opin Psychiatry; 2024 Jul; 37(4):277-281. PubMed ID: 38726805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.